All-trans retinoic acid and side-effects
- 16 May 1992
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 339 (8803) , 1239-1240
- https://doi.org/10.1016/0140-6736(92)91187-d
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia [letter; comment]Blood, 1992
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Prophylactic heparin therapy in acute promyelocytic leukemiaCancer, 1978